Apollo Medical Holdings, Inc.
AMEH
NASDAQ
$36.11
$1.313.76%
Volume241,088
05/20/2022 4:00PM Eastern
Quotes delayed
Weiss Ratings | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | -- | ||
Risk Index | Weak | -- | ||
Risk Grade | D+ | -- | ||
Reward Grade | B+ | -- | ||
Rating Factors | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
Dividend Index | -- | -- | ||
Growth Index | Excellent | -- | ||
Efficiency Index | Excellent | -- | ||
Solvency Index | Excellent | -- | ||
Total Return Index | Fair | -- | ||
Volatility Index | Weak | -- | ||
Beta / Standard Deviation | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
Beta | 1.45 | -- | ||
Price History | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
7-Day Total Return | 7.53% | -- | ||
30-Day Total Return | -18.49% | -- | ||
60-Day Total Return | -28.51% | -- | ||
90-Day Total Return | -43.82% | -- | ||
Year to Date Total Return | -46.14% | -- | ||
1-Year Total Return | 6.93% | -- | ||
2-Year Total Return | 105.87% | -- | ||
3-Year Total Return | 87.58% | -- | ||
5-Year Total Return | -- | -- | ||
52-Week High % Change | -72.90% | -- | ||
52-Week Low % Change | 22.32% | -- | ||
Price | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
52-Week High Price | $133.23 | -- | ||
52-Week Low Price | $29.52 | -- | ||
52-Week Low Price (Date) | May 12, 2022 | -- | ||
52-Week High Price (Date) | Nov 15, 2021 | -- | ||
Valuation | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
Market Cap | $1.63B | -- | ||
Enterprise Value | 1.61B | -- | ||
Price/Earnings (TTM) | 22.17 | -- | ||
Earnings Per Share (TTM) | 1.63 | -- | ||
Earnings Per Share Growth | 35.11% | -- | ||
Price/Earnings To Growth | 0.63 | -- | ||
Price/Sales (TTM) | 1.93 | -- | ||
Price/Book (Q) | 3.42 | -- | ||
Enterprise Value/Revenue (TTM) | 1.87 | -- | ||
Price | $36.11 | -- | ||
Enterprise Value/EBITDA (TTM) | 13.08 | -- | ||
Enterprise Value/EBIT | 15.27 | -- | ||
Market Cap Category | Small Cap | -- | ||
Dividends and Shares | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
Shares Outstanding | 45.995M | -- | ||
Dividend Yield | -- | -- | ||
Div. Per Share (Most Recent) | -- | -- | ||
Dividend Per Share (TTM) | -- | -- | ||
Payout Ratio (TTM) | 41.47% | -- | ||
Dividend Per Share (Most Recent) | -- | -- | ||
Company Info | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
Phone Number | 626 282 0288 | -- | ||
Address | 1668 South Garfield Avenue Alhambra, CA 91801 | -- | ||
Website | www.apollomed.net | -- | ||
Country | United States | -- | ||
Year Founded | 1994 | -- | ||
Profitability | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
Operating Margin (TTM) | 12.22% | -- | ||
Profit Margin | 8.70% | -- | ||
Management Effectiveness | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
Return on Assets | 7.50% | -- | ||
Return on Equity | 9.42% | -- | ||
Income Statement | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
Revenue (TTM) | $37.88M | -- | ||
Total Revenue (TTM) | $861.11M | -- | ||
Revenue Per Share | $18.72 | -- | ||
Gross Profit (TTM) | $184.86M | -- | ||
EBITDA (TTM) | $123.00M | -- | ||
EBIT (TTM) | $105.31M | -- | ||
Net Income (TTM) | $74.97M | -- | ||
Net Income Avl. to Common (TTM) | $74.97M | -- | ||
Total Revenue Growth (Q YOY) | 49.53% | -- | ||
Earnings Growth (Q YOY) | -16.50% | -- | ||
EPS Diluted (TTM) | $1.63 | -- | ||
EPS Diluted Growth (Q YOY) | 3.33% | -- | ||
Balance Sheet | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $280.84M | -- | ||
Cash Per Share (Q) | $6.11 | -- | ||
Total Current Assets (Q) | $444.42M | -- | ||
Total Preferred Equity (Q) | -- | -- | ||
Total Equity (Q) | $531.67M | -- | ||
Current Ratio (Q) | 2.770 | -- | ||
Book Value Per Share (Q) | $10.57 | -- | ||
Total Assets (Q) | $912.33M | -- | ||
Total Current Liabilities (Q) | $160.44M | -- | ||
Total Debt (Q) | $202.00M | -- | ||
Total Liabilities (Q) | $380.66M | -- | ||
Total Common Equity (Q) | $473.99M | -- | ||
Cash Flow | AMEH - NASDAQ | - | Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -$3.88M | -- | ||
Cash from Financing (TTM) | -$48.48M | -- | ||
Net Change in Cash (TTM) | $32.07M | -- | ||
Levered Free Cash Flow (TTM) | $31.75M | -- | ||
Cash from Operations (TTM) | $84.42M | -- | ||